1. NF-κB Immunology/Inflammation Metabolic Enzyme/Protease Stem Cell/Wnt TGF-beta/Smad
  2. Keap1-Nrf2 Reactive Oxygen Species MMP TGF-beta/Smad Endogenous Metabolite
  3. Sodium hippurate, 98%

Sodium hippurate, 98%  (Synonyms: N-Benzoylglycine sodium, 98%)

Cat. No.: HY-W014841 Purity: 99.91%
Data Sheet Handling Instructions Technical Support

Sodium hippurate, 98% is an orally active metabolite. Sodium hippurate, 98% can be produced by intestinal microorganisms from the metabolism of polyphenols, benzoic acid. Sodium hippurate, 98% decreases NRF2, MMP9 and leads to ROS accumulation. Sodium hippurate, 98% activates TGFβ/SMAD signaling. Sodium hippurate, 98% improves hyperuricemia and colitis. Sodium hippurate, 98% can also be used in cardiovascular disease research. .

For research use only. We do not sell to patients.

Sodium hippurate, 98% Chemical Structure

Sodium hippurate, 98% Chemical Structure

CAS No. : 532-94-5

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
5 g USD 25 In-stock
10 g USD 40 In-stock
50 g   Get quote  

Get it by April 4 for select sizes. Order within 14 hrs 52 mins.

* Please select Quantity before adding items.

Other Forms of Sodium hippurate, 98%:

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Sodium hippurate, 98% is an orally active metabolite. Sodium hippurate, 98% can be produced by intestinal microorganisms from the metabolism of polyphenols, benzoic acid. Sodium hippurate, 98% decreases NRF2, MMP9 and leads to ROS accumulation. Sodium hippurate, 98% activates TGFβ/SMAD signaling. Sodium hippurate, 98% improves hyperuricemia and colitis. Sodium hippurate, 98% can also be used in cardiovascular disease research[1][2][3][4]. [5][6][7][8][9].

IC50 & Target[1][2][3][4]. [5][6][7][8][9]

MMP9

 

Microbial Metabolite

 

Human Endogenous Metabolite

 

In Vitro

Sodium hippurate, 98% (Hippuric acid, 25 μM; 24 h) co-incubated with Dexamethasone (HY-14648) significantly increases C2C12 myotube diameter, abrogates dexamethasone-induced reductions in myotube protein synthesis rates, and partially attenuates the increase in proteolysis in C2C12 myotubes under atrophy-like conditions[2].
Sodium hippurate, 98% (Hippuric acid, 1-2 mM; 15 min) significantly reduces P-selectin/CD62P expression and inhibits PAC-1 activation-dependant antibody expression in platelets stimulated ex vivo via the P2Y1/P2Y12-adenosine diphosphate (ADP) pathway[3].
Sodium hippurate, 98% (Hippuric acid, 0-1000 μM; 24 h) increases fibrosis-related gene expression, extracellular matrix imbalance, and oxidative stress in HK-2 cells[4].
Sodium hippurate, 98% (Hippuric acid, 200-400 ng/mL; 24 h) increases ABCG2 expression and apical localization in Caco-2 cells[5].
Sodium hippurate, 98% (Hippuric acid, 8 mg/mL; 24 h) decreases pro-inflammatory cytokine production and promotes the expression of ZO-1 in NCM460 cells treated with dextran sulfate sodium[6].
Sodium hippurate, 98% (Hippuric acid, concentration equivalent to that in 2.5% serum from blueberry-diet-fed rats) inhibits osteoclastogenesis and osteoclast resorptive activity in nonadherent mouse bone marrow cells isolated from 4-week-old C57BL6/J mice[7].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[4]

Cell Line: HK-2 cells
Concentration: 0 μM, 62.5 μM, 125 μM, 250 μM, 500 μM, 1000 μM
Incubation Time: 24 h
Result: Increased COL1A1, VIM, and ACTA2 protein levels, and reduced CDH1 levels in a concentration-dependent manner.
Attenuated MMP9 protein levels, while increasing TIMP1 levels.
Activated TGFβ/SMAD signaling, and the fibrotic responses were mediated by ROS activation of this pathway.
Inhibited the antioxidant pathway by downregulating NRF2 protein, as shown by reduced protein expression of NRF2 and its downstream antioxidant enzymes (HO1 and NQO1).
In Vivo

Sodium hippurate, 98% (Hippuric acid, 100 mg/kg; i.p.; five times per week; 10 weeks) promotes renal fibrosis and dysfunction in 5/6 nephrectomized rats[4].
Sodium hippurate, 98% (Hippuric acid, 10 mg/kg; p.o.; daily; 4 weeks) alleviates hyperuricemia in mice by promoting intestinal urate excretion via enhancing ABCG2-mediated transport[5].
Sodium hippurate, 98% (Hippuric acid, 50-150 mg/kg; p.o.; once daily; 7 days) alleviates DSS-induced colitis in male C57BL/6J mice, as shown by reduced clinical activity, improved intestinal barrier integrity, and modulated gut microbiota[6].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Sprague Dawley rats (7-week-old, weight not specified); 5/6 nephrectomy model[4]
Dosage: 100 mg/kg
Administration: Intraperitoneal injection, five times per week, for 10 weeks
Result: Significantly increased levels of serum creatinine (SCr), blood urea nitrogen (BUN), and HA.
Showed increased tubulointerstitial fibrosis and glomerulosclerosis, with larger COL1A1-, VIM-, and ACTA2-positive areas.
Revealed lower NRF2 levels.
Decreased activities of SOD, CAT, and GSH- Px.
Increased MDA levels in the kidneys, indicating redox imbalance.
Molecular Weight

201.16

Formula

C9H8NNaO3

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

O=C(CNC(C1=CC=CC=C1)=O)O[Na]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Store at room temperature, keep dry and cool

In solvent -80°C 2 years
-20°C 1 year
Solvent & Solubility
In Vitro: 

DMSO : 33.33 mg/mL (165.69 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.9712 mL 24.8562 mL 49.7124 mL
5 mM 0.9942 mL 4.9712 mL 9.9425 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Purity & Documentation

Purity: 99.91%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 4.9712 mL 24.8562 mL 49.7124 mL 124.2810 mL
5 mM 0.9942 mL 4.9712 mL 9.9425 mL 24.8562 mL
10 mM 0.4971 mL 2.4856 mL 4.9712 mL 12.4281 mL
15 mM 0.3314 mL 1.6571 mL 3.3142 mL 8.2854 mL
20 mM 0.2486 mL 1.2428 mL 2.4856 mL 6.2141 mL
25 mM 0.1988 mL 0.9942 mL 1.9885 mL 4.9712 mL
30 mM 0.1657 mL 0.8285 mL 1.6571 mL 4.1427 mL
40 mM 0.1243 mL 0.6214 mL 1.2428 mL 3.1070 mL
50 mM 0.0994 mL 0.4971 mL 0.9942 mL 2.4856 mL
60 mM 0.0829 mL 0.4143 mL 0.8285 mL 2.0714 mL
80 mM 0.0621 mL 0.3107 mL 0.6214 mL 1.5535 mL
100 mM 0.0497 mL 0.2486 mL 0.4971 mL 1.2428 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Sodium hippurate, 98%
Cat. No.:
HY-W014841
Quantity:
MCE Japan Authorized Agent: